European Task Force on Atopic Dermatitis statement on severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) infection and atopic dermatitis

A Wollenberg; C Flohr; D Simon; M J Cork; J P Thyssen; T Bieber; M S de Bruin-Weller; S Weidinger; M Deleuran; A Taieb; C Paul; M Trzeciak; T Werfel; J Seneschal; S Barbarot; U Darsow; A Torrelo; J-F Stalder; Å Svensson; D Hijnen; C Gelmetti; Z Szalai; U Gieler; L De Raeve; B Kunz; P Spuls; L B von Kobyletzki; R Fölster-Holst; P V Chernyshov; S Christen-Zaech; A Heratizadeh; J Ring; C Vestergaard

doi:10.1111/jdv.16411

European Task Force on Atopic Dermatitis statement on severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) infection and atopic dermatitis

A Wollenberg
, C Flohr
, D Simon
, M J Cork
, J P Thyssen
, T Bieber
, M S de Bruin-Weller
, S Weidinger
, M Deleuran
, A Taieb
, C Paul
, M Trzeciak
, T Werfel
, J Seneschal
, S Barbarot
, U Darsow
, A Torrelo
, J-F Stalder
, Å Svensson
, D Hijnen

C Gelmetti, Z Szalai, U Gieler, L De Raeve, B Kunz, P Spuls, L B von Kobyletzki, R Fölster-Holst, P V Chernyshov, S Christen-Zaech, A Heratizadeh, J Ring, C Vestergaard

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

1 Downloads (Pure)

Original language	English
Pages (from-to)	e241-e242
Journal	JEADV : journal of the European Academy of Dermatology and Venereology
Volume	34
Issue number	6
DOIs	https://doi.org/10.1111/jdv.16411
Publication status	Published - 1 Jun 2020

Keywords

Advisory Committees
COVID-19
Comorbidity
Coronavirus Infections/epidemiology
Dermatitis, Atopic/drug therapy
Europe
Female
Humans
Immunocompromised Host/drug effects
Immunosuppressive Agents/therapeutic use
Male
Pandemics
Pneumonia, Viral/epidemiology
Practice Guidelines as Topic
Risk Assessment
Severe Acute Respiratory Syndrome/epidemiology
Treatment Outcome

Access to Document

10.1111/jdv.16411

Acad Dermatol Venereol - 2020 - Wollenberg - European Task Force on Atopic Dermatitis statement on severe acute respiratoryFinal published version, 100 KBLicence: Taverne

Cite this

Wollenberg, A., Flohr, C., Simon, D., Cork, M. J., Thyssen, J. P., Bieber, T., de Bruin-Weller, M. S., Weidinger, S., Deleuran, M., Taieb, A., Paul, C., Trzeciak, M., Werfel, T., Seneschal, J., Barbarot, S., Darsow, U., Torrelo, A., Stalder, J.-F., Svensson, Å., ... Vestergaard, C. (2020). European Task Force on Atopic Dermatitis statement on severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) infection and atopic dermatitis. JEADV : journal of the European Academy of Dermatology and Venereology, 34(6), e241-e242. https://doi.org/10.1111/jdv.16411

@article{83a3a4fc2a9140a38d8cf069d39f818c,

title = "European Task Force on Atopic Dermatitis statement on severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) infection and atopic dermatitis",

keywords = "Advisory Committees, COVID-19, Comorbidity, Coronavirus Infections/epidemiology, Dermatitis, Atopic/drug therapy, Europe, Female, Humans, Immunocompromised Host/drug effects, Immunosuppressive Agents/therapeutic use, Male, Pandemics, Pneumonia, Viral/epidemiology, Practice Guidelines as Topic, Risk Assessment, Severe Acute Respiratory Syndrome/epidemiology, Treatment Outcome",

author = "A Wollenberg and C Flohr and D Simon and Cork, \{M J\} and Thyssen, \{J P\} and T Bieber and \{de Bruin-Weller\}, \{M S\} and S Weidinger and M Deleuran and A Taieb and C Paul and M Trzeciak and T Werfel and J Seneschal and S Barbarot and U Darsow and A Torrelo and J-F Stalder and {\AA} Svensson and D Hijnen and C Gelmetti and Z Szalai and U Gieler and \{De Raeve\}, L and B Kunz and P Spuls and \{von Kobyletzki\}, \{L B\} and R F{\"o}lster-Holst and Chernyshov, \{P V\} and S Christen-Zaech and A Heratizadeh and J Ring and C Vestergaard",

year = "2020",

month = jun,

day = "1",

doi = "10.1111/jdv.16411",

language = "English",

volume = "34",

pages = "e241--e242",

journal = "JEADV : journal of the European Academy of Dermatology and Venereology",

issn = "0926-9959",

publisher = "John Wiley \& Sons Inc.",

number = "6",

}

Wollenberg, A, Flohr, C, Simon, D, Cork, MJ, Thyssen, JP, Bieber, T, de Bruin-Weller, MS, Weidinger, S, Deleuran, M, Taieb, A, Paul, C, Trzeciak, M, Werfel, T, Seneschal, J, Barbarot, S, Darsow, U, Torrelo, A, Stalder, J-F, Svensson, Å, Hijnen, D, Gelmetti, C, Szalai, Z, Gieler, U, De Raeve, L, Kunz, B, Spuls, P, von Kobyletzki, LB, Fölster-Holst, R, Chernyshov, PV, Christen-Zaech, S, Heratizadeh, A, Ring, J & Vestergaard, C 2020, 'European Task Force on Atopic Dermatitis statement on severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) infection and atopic dermatitis', JEADV : journal of the European Academy of Dermatology and Venereology, vol. 34, no. 6, pp. e241-e242. https://doi.org/10.1111/jdv.16411

European Task Force on Atopic Dermatitis statement on severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) infection and atopic dermatitis. / Wollenberg, A; Flohr, C; Simon, D et al.
In: JEADV : journal of the European Academy of Dermatology and Venereology, Vol. 34, No. 6, 01.06.2020, p. e241-e242.

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

TY - JOUR

T1 - European Task Force on Atopic Dermatitis statement on severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) infection and atopic dermatitis

AU - Wollenberg, A

AU - Flohr, C

AU - Simon, D

AU - Cork, M J

AU - Thyssen, J P

AU - Bieber, T

AU - de Bruin-Weller, M S

AU - Weidinger, S

AU - Deleuran, M

AU - Taieb, A

AU - Paul, C

AU - Trzeciak, M

AU - Werfel, T

AU - Seneschal, J

AU - Barbarot, S

AU - Darsow, U

AU - Torrelo, A

AU - Stalder, J-F

AU - Svensson, Å

AU - Hijnen, D

AU - Gelmetti, C

AU - Szalai, Z

AU - Gieler, U

AU - De Raeve, L

AU - Kunz, B

AU - Spuls, P

AU - von Kobyletzki, L B

AU - Fölster-Holst, R

AU - Chernyshov, P V

AU - Christen-Zaech, S

AU - Heratizadeh, A

AU - Ring, J

AU - Vestergaard, C

PY - 2020/6/1

Y1 - 2020/6/1

KW - Advisory Committees

KW - COVID-19

KW - Comorbidity

KW - Coronavirus Infections/epidemiology

KW - Dermatitis, Atopic/drug therapy

KW - Europe

KW - Female

KW - Humans

KW - Immunocompromised Host/drug effects

KW - Immunosuppressive Agents/therapeutic use

KW - Male

KW - Pandemics

KW - Pneumonia, Viral/epidemiology

KW - Practice Guidelines as Topic

KW - Risk Assessment

KW - Severe Acute Respiratory Syndrome/epidemiology

KW - Treatment Outcome

UR - https://www.scopus.com/pages/publications/85083156285

U2 - 10.1111/jdv.16411

DO - 10.1111/jdv.16411

M3 - Comment/Letter to the editor

C2 - 32223003

SN - 0926-9959

VL - 34

SP - e241-e242

JO - JEADV : journal of the European Academy of Dermatology and Venereology

JF - JEADV : journal of the European Academy of Dermatology and Venereology

IS - 6

ER -

European Task Force on Atopic Dermatitis statement on severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) infection and atopic dermatitis

Keywords

Access to Document

Other files and links

Cite this